Guillermo
Debén Ariznavarreta
Hospital Universitario Araba
Vitoria, EspañaPublications in collaboration with researchers from Hospital Universitario Araba (2)
2021
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433